Capricor Therapeutics reported $-30.17M in Net Income for its fiscal quarter ending in December of 2025.





Net Income Change Date
Alterity Therapeutics Limited AUD -6.3M 525.41K Dec/2025
Bioline Rx USD -1.6M 635K Mar/2026
Capricor Therapeutics USD -30.17M 5.6M Dec/2025
Cipla INR 7.89B 2.34B Jun/2026
Cytokinetics USD -206.03M 23M Mar/2026
Geron USD -3.64M 27.5M Mar/2026
Grifols EUR 114.37M 34.03M Dec/2025
Immunic USD -19.3M 6.28M Dec/2025
J&J USD 5.53B 299M Jun/2026
Plus Therapeutics USD -5.71M 1.29M Dec/2025
Prothena USD 32.72M 54.31M Mar/2026
PTC Therapeutics USD -2.81M 132.16M Mar/2026
Sarepta Therapeutics USD 330.96M 743.18M Mar/2026